Get Aware Of Lucrative PCD Products To Start Company

| December 27, 2019

article image
Pharma franchise is an agreement or authorized permission or sanction established by pharma company to suppliers, group or separate company Franchise Company offers privileges to franchisee to expand its business with the benefit of Franchise Company. In the past few years, it has been seen a tremendous growth in every sector; the pharmaceutical sector is also not an exception. Pharma franchise is even called as PCD, which means propaganda cum distribution, pharma business means, and a firm has its own industrial capacity. Business is same to any sort of Franchise business. It is the accountability of franchisee to spread and issue the products in his region. Anybody who has the in-depth knowledge of pharmaceutical marketplace is the correct candidate for PCD model. Well, looking out for a PCD pharma franchise can be a grand proposal from the effectiveness perspective. Since it is like possessing an individual business, the extra efforts one puts in, the additional profits achieved. Pharma franchise gives you one such platform that gives best opportunities to you

Spotlight

Getz Pharma

Getz Pharma is world-class branded generic pharmaceutical company with a global outlook. The company's mission is develop, produce and market safe, effective and quality medicines and healthcare products that will improve the health and quality of life of men, women and children.

OTHER ARTICLES

Pricing of drugs – at what cost?

Article | February 27, 2020

We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros copay. But how is a drug priced in Germany? And (how) does data play a role in helping pharma secure an attractive price point? Let’s fast forward directly to the launch of a new drug. At the time of launch, the pharmaceutical company has to present patient level evidence of the drug’s added value compared to existing comparative therapies. In the first year, however, the drug’s price can be defined freely by the company.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | February 27, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | February 27, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | February 27, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Spotlight

Getz Pharma

Getz Pharma is world-class branded generic pharmaceutical company with a global outlook. The company's mission is develop, produce and market safe, effective and quality medicines and healthcare products that will improve the health and quality of life of men, women and children.

Events